



Chikungunya fever is a viral disease
transmitted to humans by the bite of
infected mosquitoes. Chikungunya virus
(CHIKV) is a member of the genus
Alphavirus, in the family Togaviridae.
CHIKV was first isolated from the blood
of a febrile patient in Tanzania in 1953,
and has since been identified repeatedly
in west, central and southern Africa and
many areas of Asia, and has been cited
as the cause of numerous human
epidemics in those areas since that
time. The virus circulates throughout
much of Africa, with transmission
thought to occur mainly between
mosquitoes and monkeys.  This disease
is almost always self-limited and rarely
fatal. In addition to ongoing outbreaks
on the Indian Ocean islands of Mayotte,
Mauritius, Riunion (territory of France),
and the Seychelles, a chikungunya fever
outbreak has been reported from three
states in India (Karnataka, Maharastra,
and Andra Pradesh). Travelers to all
these areas are recommended to take
precautions to avoid mosquito bites.
What type of illness does
chikungunya virus cause?
CHIKV infection can cause a debilitating
illness, most often characterized by
fever, headache, fatigue, nausea,
vomiting, muscle pain, rash, and joint
pain.  The term ‘chikungunya’ is Swahili
for ‘that which bends up’. The incubation
period (time from infection to illness)
can be 2-12 days, but is usually 3-7
days. Silent CHIKV infections (infections
without illness) do occur; but how
commonly this happens is not yet
known.
Acute chikungunya fever typically
lasts a few days to a couple of weeks,
but as with dengue, West Nile fever,
o'nyong-nyong fever and other arboviral
fevers, some patients have prolonged
fat igue last ing several weeks.
Additionally, some patients have
reported incapacitating joint pain, or
arthritis which may last for weeks or
months. The prolonged joint pain
associated with CHIKV is not typical of
dengue. Co-circulation of dengue fever
in many areas may mean that
chikungunya fever cases are sometimes
clinically misdiagnosed as dengue
infections, therefore the incidence of
chikungunya fever could be much
higher than what has been previously
reported. No deaths, neuroinvasive
cases, or hemorrhagic cases related to
CHIKV infection have been conclusively
documented in the scientific literature.
CHIKV infection (whether clinical or
silent) is thought to confer life-long
immunity.
How do humans become
infected with chikungunya virus?
CHIKV is spread by the bite of an
infected mosquito. Mosquitoes become
infected when they feed on a person
infected with CHIKV. Monkeys, and
possibly other wild animals, may also
serve as reservoirs of the virus. Infected
mosquitoes can then spread the virus
to other humans when they bite. Aedes
aegypti (the yellow fever mosquito), a
household container breeder and
aggressive daytime biter which is
attracted to humans, is the primary
vector of CHIKV to humans. Aedes
albopictus (the Asian tiger mosquito)
may also play a role in human
transmission in Asia, and various forest-
dwelling mosquito species in Africa
have been found to be infected with the
virus.
Where does chikungunya virus
occur?
The geographic range of the virus is
Africa and Asia. For information on
current outbreaks, consult CDC’s
website below. Given the current large
CHIKV epidemics and the world wide
distribution of Aedes aegypti, there is
a risk of importation of CHIKV into new
areas by infected travelers.
Preventive measures
There are no preventive medications or
F D A - a p p ro v e d  v a c c i n e s  f o r
chikungunya fever, but there are steps
travelers can take to reduce their risk
of being bitten by infected mosquitoes.
Use insect repellent on exposed skin
surfaces when outdoors, particularly
during the day. Repellents containing
30% to 50% DEET (N,N-diethyl-m-
toluamide) are recommended. Lower
concentrations of DEET offer shorter-
term protection requiring more frequent
reapplication. Repellents containing
picaridin are available in the U.S. only
in low-concentration (7%) formulations,
which require frequent reapplication.
Repellents with higher concentration
formulations of picaridin may be
available in some regions outside the
U.S.
Wear long-sleeved shirts and long
pants when outdoors.
Clothing may also be sprayed with
repellent containing permethrin or
another EPA-registered repellent for
greater protection. Stay in hotels or
resorts that are well screened or air-
conditioned and that take measures
to reduce the mosquito population,
where possible. Reduce Aedes
breeding sites by emptying standing
water that may have collected in
containers (e.g., uncovered barrels,
flower vases, or cisterns) and either
overturning the vessels or covering
the opening. If illness develops, stay
under a mosquito net or indoors to
limit mosquito bites and to avoid
further spread of infection.
These preventive measures are the
same steps that one would take to
reduce the risk of other mosquito
transmitted infectious diseases such as
dengue and yellow fever.
Treatment
No specific drug treatment against
chikungunya virus is available; thus,
treatment of chikungunya fever is
supportive: bed rest, fluids, and mild
pain medications such as ibuprofen,
naproxen,  acetaminophen,  or
paracetamol may relieve symptoms of
fever and aching. Because aspirin can
increase the risk of bleeding and
possibly Reye syndrome, it should be
avoided during the acute stages of the
illness. Few cases are severe enough
to warrant hospitalization. All persons
with chikungunya fever should be
protected against additional mosquito
bites to reduce the risk of further
transmission of the virus.
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FOR MORE INFORMATION see http://www.cdc.gov/ncidod/dvbid/Chikungunya/chickvfact.htm
